News
After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...
1d
Zacks Investment Research on MSN4 Attractive GARP Picks for Your Portfolio Based on PEG RatioIn the equity market, investments always need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether one should resort to ...
CVS Health Ventures, the venture capital arm of CVS Health, participated in a $45 million Series A funding round for AI healthcare company Ellipsis Health. The round was led by Salesforce and Khosla ...
The closure will impact residents like Lou Cohick, who has cerebral palsy and valued the store's accessibility and ...
The Gabelli Pet Parents Fund ( MUTF: PETZX) was down 7.28% in Q1 2025. The largest contributors in the quarter were CVS ...
Retail pharmacy powerhouse, CVS Health CVS, is advancing its digital-first strategy and investing in emerging technologies as part of its long-term growth plan. The company recently announced plans to ...
Synergy CHC Corp. (NASDAQ: SNYR) , a provider of consumer health and lifestyle products, most notably “Focusfactor” , today ...
Lifeway reported a notable 10.7% increase in net sales for the first two months of the second quarter, reaching $37.6 million, compared to the same period last year. The company’s year-to-date net ...
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the first quarter ended April 30, 2025.
Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the first quarter ended April 30, 2025. Nutriband is continuing to expand its kinesiology tape output through its Pocono ...
14d
Explícame on MSNCVS closures raise fears of 'pharmacy deserts' with 270 more locations set to shut in 2025CVS will close 270 more stores by 2025 to streamline operations, sparking concerns over reduced pharmacy access in vulnerable ...
NEW YORK — CVS Health said the drugs Wegovy and Saxenda ... That allows pharmacy benefit managers to pit the products against each other to negotiate lower prices in exchange for inclusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results